90-325.6. No private right of action against manufacturers of investigational drugs, biological products, or devices.
No private right of action may be brought against a manufacturer of an investigational drug, biological product, or device, or against any other person or entity involved in the care of an eligible patient using an investigational drug, biological product, or device, for any harm caused to the eligible patient resulting from use of the investigational drug, biological product, or device as long as the manufacturer or other person or entity has made a good-faith effort to comply with the provisions of this Part and has exercised reasonable care in actions undertaken pursuant to this Part. (2015-137, s. 1; 2019-70, s. 1.)
Structure North Carolina General Statutes
North Carolina General Statutes
Chapter 90 - Medicine and Allied Occupations
Article 23A - Right to Try Act.
§ 90-325 - Short title; purpose.
§ 90-325.4 - Sanctions against health care providers prohibited.
§ 90-325.5 - Prohibited conduct by State officials.
§ 90-325.7 - Insurance coverage of clinical trials.
§ 90-325.17 - Authorized treatments.
§ 90-325.18 - Institutional review boards; annual report; rules.
§ 90-325.20 - Sanctions against physicians prohibited.